- Report
- August 2024
- 125 Pages
Asia Pacific
From €3072EUR$3,450USD£2,655GBP
- Report
- August 2024
- 128 Pages
Europe
From €3072EUR$3,450USD£2,655GBP
- Report
- August 2024
- 117 Pages
North America
From €3072EUR$3,450USD£2,655GBP
- Report
- August 2024
- 112 Pages
From €3072EUR$3,450USD£2,655GBP
- Report
- August 2024
- 118 Pages
Africa, Middle East
From €3072EUR$3,450USD£2,655GBP
- Report
- February 2024
- 196 Pages
Global
From €3962EUR$4,450USD£3,424GBP
- Report
- March 2022
- 155 Pages
Global
From €3962EUR$4,450USD£3,424GBP
- Report
- February 2024
- 188 Pages
Global
From €4006EUR$4,500USD£3,462GBP
- Report
- November 2023
- 140 Pages
Global
From €3170EUR$3,560USD£2,739GBP
€3962EUR$4,450USD£3,424GBP
- Report
- January 2024
- 300 Pages
Global
From €1113EUR$1,250USD£962GBP
€2226EUR$2,500USD£1,924GBP
- Report
- August 2024
- 200 Pages
Global
From €4406EUR$4,949USD£3,808GBP
- Report
- July 2024
- 200 Pages
Global
From €4406EUR$4,949USD£3,808GBP
- Report
- June 2024
- 140 Pages
Europe
From €3445EUR$3,869USD£2,977GBP
- Report
- June 2024
- 140 Pages
Middle East, Africa
From €3445EUR$3,869USD£2,977GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3445EUR$3,869USD£2,977GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3445EUR$3,869USD£2,977GBP
- Report
- April 2024
- 140 Pages
Global
From €4406EUR$4,949USD£3,808GBP
- Report
- November 2023
- 140 Pages
Global
From €3204EUR$3,599USD£2,769GBP
- Report
- August 2023
- 168 Pages
Global
From €3204EUR$3,599USD£2,769GBP
- Report
- May 2023
- 147 Pages
Global
From €4406EUR$4,949USD£3,808GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more